Tetracosactide - Novartis

Drug Profile

Tetracosactide - Novartis

Alternative Names: Corticotropin tetracosapeptide; Cosyntropin; Cosyntropin zinc hydroxide injection; Synacthen; Synacthen Depot; Tetracosactide hexa-acetate salt - Novartis

Latest Information Update: 26 Aug 2016

Price : $50

At a glance

  • Originator Novartis
  • Developer Alliance Pharmaceuticals Limited; Defiante Farmaceutica; Mallinckrodt plc; Novartis; Sigma-Tau Pharmaceuticals; Swedish Orphan Biovitrum
  • Class Corticosteroids; Melanocortins; Peptides
  • Mechanism of Action Melanocortin receptor agonists; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    Duchenne muscular dystrophy
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Adrenal insufficiency; Autoimmune disorders; Infantile spasms; Inflammation; Multiple sclerosis
  • Phase I Duchenne muscular dystrophy

Most Recent Events

  • 25 Aug 2016 Phase-I clinical trials in Duchenne muscular dystrophy in USA (Parenteral)
  • 25 Aug 2016 Tetracosactide - Mallinckrodt plc receives Fast Track designation for Duchenne muscular dystrophy [Parenteral,Injection] in USA
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in USA (Parenteral, Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top